The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19 Read more about The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment Read more about Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients Read more about Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients
Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial Read more about Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children Read more about A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
Frequency of SARS COVID-19 Infection Among Malignant Patients at South Egypt Cancer Institute Read more about Frequency of SARS COVID-19 Infection Among Malignant Patients at South Egypt Cancer Institute
A Study of Baricitinib (LY3009104) in Children With COVID-19 Read more about A Study of Baricitinib (LY3009104) in Children With COVID-19
NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19 Read more about NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19
Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3 Read more about Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3
Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON) Read more about Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)
